Thursday, November 12, 2009

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
FDA approves tapentadol for acute pain

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

FDA approves tapentadol for acute pain

(Doctor's Guide News) UPDATED 2008-11-21

The U.S. Food and Drug Administration (FDA) has approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults. The FDA's move was based on the drug's ability to significantly reduce acute pain in a number of clinical trials. These trials included more than 2,100 patients who were suffering from such conditions as hip and knee osteoarthritis, end-stage joint disease, low back pain, and pain related to bunionectomy procedures. Read full story >

See all Rheumatoid Arthritis News

Related: tapentadol

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.